Dialog Box

Rare Cancers Australia

Ep 6: Professor Grant McArthur

Professor Grant McArthur

Executive Director, VCCC Alliance
Head of the Molecular Oncology Lab, Peter Mac
Thinking big: how we can make a difference for patients

In this episode, RCA Chief Executive Richard Vines speaks to Professor Grant McArthur about:

  • The challenges of personalising cancer treatment
  • How the moon landing sparked a career in medicine
  • Why he chose to specialise in cancer, and melanoma
  • What gets him out of bed in the morning, and what drives him
  • The vision of the VCCC, and how it came about
  • Why he moved from a full-time research and clinical role to a leadership position
  • The sensitivities around prescribing medications that are not PBS funded
  • The gaps between published evidence, TGA approval and PBS listing
  • Ideas on how to speed up patient access to life-extending and life-saving treatment
  • The challenges and opportunities of developing combination treatments
  • How we can continue to improve cancer outcomes in the next 10 years
Listen to the episode as a podcast

Read Transcript Here 

More about Professor Grant McArthur

Grant is the Executive Director of the VCCC Alliance, a powerful partnership of 10 leading research, academic and clinical institutions, working together to fundamentally reshape the way we tackle cancer. Grant is also Head of the Molecular Oncology Lab at the Peter MacCallum Cancer Centre, and a highly cited melanoma researcher.

More about Richard Vines

Richard is the co-Founder and Chief Executive of Rare Cancers Australia. He is Convener and Co-chair of the National Oncology Alliance, and Deputy Chair of Omico. Richard also serves as an associate investigator on several research projects and is a spokesperson for cancer patient advocacy issues in both Australia and the Asia Pacific region.